Insider and congress filings

Tempus AI, Inc. (TEM)

NASDAQ · Healthcare · 399 insider filings · 1 congress trade · last filed 8 days ago

20
Open-market insider filings shown
2d
Median delay on the insider filings
within the two business day rule
0/20
Purchases and sales in the filings shown

About Tempus AI, Inc.

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Chief executive
Eric Lefkofsky
Employees
3,800
Listed since
Jun 14, 2024
Market value
$10.7B
Price to earnings
-
Earnings per share
-$1.41
Dividend yield
-

www.tempus.com

Earnings

6 reported quarters · next on Nov 21, 2016
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 30, 2026-$0.04-$0.14$382.5M$379.7MEPS beatRevenue in line
Q1 FY2026reported May 5, 2026-$0.13-$0.21$348.1M$345.4MEPS beatRevenue in line
Q4 FY2025reported Feb 24, 2026-$0.04-$0.04$367.2M$362.6MEPS beatRevenue in line
Q3 FY2025reported Nov 4, 2025-$0.11-$0.17$334.2M$328.7MEPS beatRevenue beat
Q2 FY2025reported Aug 8, 2025-$0.22-$0.23$314.6M$297.7MEPS beatRevenue beat
Q1 FY2025reported May 6, 2025-$0.24-$0.26$255.7M$248.1MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 7, 2026
ExecutiveSalaryStock awardsOtherTotal
Eric LefkofskyChief Executive Officer, Founder and Chairman$783K$40.0M$720K$41.5M
Ryan FukushimaChief Executive Officer, Data$423K$10.7M$526K$11.6M
Andrew PolovinExecutive Vice President, Chief Legal Officer and Secr$610K$5.7M$275K$6.6M
James RogersChief Financial Officer$500K$5.6M$225K$6.4M
Erik PhelpsExecutive Vice President, Chief Administrative and Leg$610K$3.6M$373K$4.6M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
ARK Investment Management LLC$580.6M10,022,634+4.3%5.57%
Blackrock, Inc.$480.3M8,291,053-7.6%4.61%
Baillie Gifford & Co$474.5M8,190,133-5.3%4.55%
Softbank Group Corp.$313.1M5,405,4060.0%3.00%
Susquehanna International Group, LLP$309.1M5,336,400+23.3%2.97%
Jpmorgan Chase & Co$291.2M4,989,062+1.1%2.77%
Vanguard Capital Management LLC$289.0M4,988,038+1.4%2.77%
Vanguard Portfolio Management LLC$284.7M4,914,410+5.0%2.73%
Jane Street Group, LLC$282.8M4,881,200+107.9%2.71%
Sumitomo Mitsui Trust Group, Inc.$236.9M4,089,029-5.5%2.27%
Nikko Asset Management Americas, Inc.$236.6M4,089,029-5.5%2.27%
Goldman Sachs Group Inc$217.9M3,761,666+194.4%2.09%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next TEM filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

20 filings of 399 on record
InsiderActionSharesPriceValueTrade dateDelay
Ryan FukushimaCEO, DataSold · scheduled · 4 lines30,846$62.71$1.9MSep 1, 20262d
Jennifer A. DoudnaDirectorSold · scheduled676$65.55$44KSep 1, 20262d
David R. EpsteinDirectorSold · scheduled250$65.55$16KSep 1, 20262d
Nadja WestDirectorSold · scheduled3,000$69.00$207KAug 28, 20264d
Eric P. LefkofskyCEO and ChairmanSold · scheduled · 30 lines238,152$68.39$16.3MAug 25, 20262d
Eric P. LefkofskyCEO and ChairmanSold · scheduled · 2 lines11,848$69.87$828KAug 25, 20262d
Thomas Edward SchoenherrCEO, DiagnosticsSold · scheduled2,694$70.00$189KAug 21, 20264d
Ryan FukushimaCEO, DataSold · scheduled14,286$70.00$1.0MAug 21, 20264d
Thomas Edward SchoenherrCEO, DiagnosticsSold · 6 lines8,082$58.40$472KAug 19, 20261d
James William RogersChief Financial OfficerSold22,529$49.61$1.1MAug 18, 20262d
Andrew PolovinEVP, Chief Legal OfficerSold22,148$49.61$1.1MAug 18, 20262d
Ryan FukushimaCEO, DataSold41,095$49.61$2.0MAug 18, 20262d
Thomas Edward SchoenherrCEO, DiagnosticsSold9,232$49.61$458KAug 18, 20262d
Ryan M. BartolucciChief Accounting OfficerSold6,175$49.61$306KAug 18, 20262d
James William RogersChief Financial OfficerSold26,313$60.00$1.6MAug 19, 20261d
Andrew PolovinEVP, Chief Legal OfficerSold7,927$56.00$444KAug 19, 20261d
Eric P. LefkofskyCEO and ChairmanSold132,591$49.61$6.6MAug 18, 20262d
Nadja WestDirectorSold3,000$53.90$162KAug 14, 20264d
Ryan FukushimaCEO, DataSold20,000$50.04$1.0MAug 7, 20264d
Ryan FukushimaCEO, DataSold · 5 lines23,818$46.19$1.1MAug 3, 20262d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in TEM

1 disclosure of 1 on record · median 7d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Nancy PelosiSpouseStockPurchase$50,001 - $100,000-12.9%S&P +10.2% · vs S&P 500 -23.0%Jan 16, 2026Jan 23, 20267d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

2 members · estimate, as of Sep 10, 2026

2 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Nancy PelosiDemocrat · House$50,001 - $100,000<0.1%
Robert BresnahanRepublican · House$1,001 - $15,0000.1%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (3)
InsiderEventSharesDate
Ryan FukushimaCEO, DataGift62,239Aug 12, 2026
James William RogersChief Financial OfficerStock award40,000Jul 29, 2026
Andrew PolovinEVP, Chief Legal OfficerStock award40,000Jul 29, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling TEM?

Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. 8 were scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded TEM?

Nancy Pelosi disclosed TEM transactions in the filings shown here.

Which members of Congress hold TEM?

2 members of Congress report a position in TEM in the estimate we hold as of Sep 10, 2026. The two largest estimated positions belong to Nancy Pelosi and Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are TEM trades disclosed?

Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 7 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track